Shanghai, China

Guohuang Fan

This inventor holds 3 USPTO granted patents and 6 published patent applications. Top assignee: Nanjing Immunophage Biotech Co., Ltd.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guohuang Fan. Retrieved from https://idiyas.com/inventor/guohuang-fan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Guohuang Fan: Innovator in Anti-Cancer Antibodies

Introduction

Guohuang Fan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for diagnosing and treating various cancers.

Latest Patents

Guohuang Fan holds a patent for "Anti-ROR1 antibodies and preparation method and uses thereof." This invention relates to anti-ROR1 antibodies and methods of using them. The anti-ROR1 antibodies described in this patent are particularly useful for the diagnosis and treatment of diseases associated with aberrant expression of ROR1, including various types of cancer. He has 1 patent to his name.

Career Highlights

Guohuang Fan is currently associated with Nanjing Immunophage Biotech Co., Ltd., where he continues to advance his research in antibody development. His work has garnered attention for its potential impact on cancer therapies.

Collaborations

Guohuang Fan collaborates with Jianfei Wang, contributing to the innovative research environment at Nanjing Immunophage Biotech Co., Ltd. Their combined expertise enhances the development of novel therapeutic solutions.

Conclusion

Guohuang Fan's contributions to the field of biotechnology, particularly in the development of anti-ROR1 antibodies, highlight his role as an innovator in cancer treatment. His work continues to pave the way for advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…